2014
DOI: 10.2220/biomedres.35.207
|View full text |Cite
|
Sign up to set email alerts
|

A novel biomarker for acute kidney injury using TaqMan-based unmethylated DNA-specific polymerase chain reaction

Abstract: There has been increasing interest in the use of circulating DNA as biomarkers for various tissue injuries, cancers, and fetal conditions. DNA methylation is a well-characterized mechanism underlying the epigenetic regulation of gene expression, and many diagnostic tests based on DNA methylation patterns have been developed. We developed a novel TaqMan-based assay for the detection of acute kidney injury using a hypomethylated promoter region of Slc22a12, a urate transporter specifically expressed in proximal … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
7
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 10 publications
(7 citation statements)
references
References 22 publications
0
7
0
Order By: Relevance
“…DNA was bisulfite-converted using a MethylEdge Bisulfite Conversion System (Promega, WI, USA), following the manufacturer's recommendations. Fragments including the target site were PCR-amplified from the bisulfite-converted DNA using primer sets ( Table 1 ) with EpiTaq HS DNA polymerase (TAKARA, Shiga, Japan) as described previously [ 15 ]. The PCR product was cloned into the pTA2 vector using a TArget Clone Plus cloning kit (TOYOBO, Osaka, Japan).…”
Section: Methodsmentioning
confidence: 99%
“…DNA was bisulfite-converted using a MethylEdge Bisulfite Conversion System (Promega, WI, USA), following the manufacturer's recommendations. Fragments including the target site were PCR-amplified from the bisulfite-converted DNA using primer sets ( Table 1 ) with EpiTaq HS DNA polymerase (TAKARA, Shiga, Japan) as described previously [ 15 ]. The PCR product was cloned into the pTA2 vector using a TArget Clone Plus cloning kit (TOYOBO, Osaka, Japan).…”
Section: Methodsmentioning
confidence: 99%
“…Circulating or urinary microRNAs are being evaluated (92), and kidney-specific DNA methylation patterns are also being analyzed (93). Recent attention has also focused on urinary extracellular vesicles (94), which contain mRNA, microRNA, and proteins reflective of cellular physiology and pathophysiology along the nephron.…”
Section: Biomarkersmentioning
confidence: 99%
“…Furthermore, there was a trend toward increased aberrant hypermethylation of urine CALCA in patients with biopsy-proven acute tubular necrosis versus acute rejection and slow or prompt graft function [28]. Plasma levels of unmethylated DNA corresponding to the Slc22a12 promoter region, a urate transporter specifically expressed in proximal tubular cells, were undetectable at baseline and were significantly elevated after acute kidney cortex necrosis [29]. Methylation of promoter kallikrein (KLK1) CpG in the kidney was higher in blood than urine DNA, while KLK1 methylation in blood DNA was higher in established AKI than healthy controls, though KLK1 methylation in urine tended to be elevated in AKI, directionally consistent with earlier/incipient but not later/established changes in KLK1 excretion in AKI [30].…”
Section: Methylation and Acute Kidney Injurymentioning
confidence: 99%